These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29526456)

  • 1. Early treatment resistance in a Latin-American cohort of patients with schizophrenia.
    Mena C; Gonzalez-Valderrama A; Iruretagoyena B; Undurraga J; Crossley NA
    Schizophr Res; 2018 Sep; 199():380-385. PubMed ID: 29526456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine use in early psychosis.
    Thien K; Bowtell M; Eaton S; Bardell-Williams M; Downey L; Ratheesh A; McGorry P; O'Donoghue B
    Schizophr Res; 2018 Sep; 199():374-379. PubMed ID: 29525463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early use of clozapine for poorly responding first-episode psychosis.
    Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
    J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
    Lally J; Ajnakina O; Di Forti M; Trotta A; Demjaha A; Kolliakou A; Mondelli V; Reis Marques T; Pariante C; Dazzan P; Shergil SS; Howes OD; David AS; MacCabe JH; Gaughran F; Murray RM
    Psychol Med; 2016 Nov; 46(15):3231-3240. PubMed ID: 27605254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine Use in a Cohort of First-Episode Psychosis.
    Doyle R; Behan C; OʼKeeffe D; Masterson S; Kinsella A; Kelly A; Sheridan A; Keating D; Hynes C; Madigan K; Lawlor E; Clarke M
    J Clin Psychopharmacol; 2017 Oct; 37(5):512-517. PubMed ID: 28650930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial.
    Girgis RR; Phillips MR; Li X; Li K; Jiang H; Wu C; Duan N; Niu Y; Lieberman JA
    Br J Psychiatry; 2011 Oct; 199(4):281-8. PubMed ID: 21292928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical and temporal variations in clozapine prescription for schizophrenia.
    Nielsen J; Røge R; Schjerning O; Sørensen HJ; Taylor D
    Eur Neuropsychopharmacol; 2012 Nov; 22(11):818-24. PubMed ID: 22503785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
    Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
    Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland.
    Ingimarsson O; MacCabe JH; Sigurdsson E
    Nord J Psychiatry; 2018 Oct; 72(7):497-500. PubMed ID: 30348045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study.
    Wimberley T; Støvring H; Sørensen HJ; Horsdal HT; MacCabe JH; Gasse C
    Lancet Psychiatry; 2016 Apr; 3(4):358-66. PubMed ID: 26922475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between delay in initiating clozapine and symptomatic improvement.
    Yada Y; Yoshimura B; Kishi Y
    Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between season of birth, age at onset, and clozapine use in schizophrenia.
    Kim JS; Park CM; Choi JA; Park E; Tchoe HJ; Choi M; Suh JK; Kim YH; Won SH; Chung YC; Bae KY; Lee SK; Park SC; Lee SH
    Acta Psychiatr Scand; 2017 Nov; 136(5):445-454. PubMed ID: 28741647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
    Drosos P; Brønnick K; Joa I; Johannessen JO; Johnsen E; Kroken RA; Stain HJ; Hegelstad WTV; Larsen TK
    J Clin Psychopharmacol; 2020; 40(6):534-540. PubMed ID: 33136922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: results after one year.
    Sanz-Fuentenebro J; Taboada D; Palomo T; Aragües M; Ovejero S; Del Alamo C; Molina V
    Schizophr Res; 2013 Sep; 149(1-3):156-61. PubMed ID: 23870807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia.
    Maher KN; Tan M; Tossell JW; Weisinger B; Gochman P; Miller R; Greenstein D; Overman GP; Rapoport JL; Gogtay N
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):110-6. PubMed ID: 23510445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.